MacroGenics
MGNX
#8495
Rank
โ‚น20.77 B
Marketcap
โ‚น326.80
Share price
1.15%
Change (1 day)
199.06%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.66. In 2024 the company made an earnings per share (EPS) of -โ‚น99.62 a decrease over its 2023 EPS that were of -โ‚น13.97.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-95%
2024-โ‚น99.62613.33%
2023-โ‚น13.97-92.31%
2022-โ‚น181.56-42.14%
2021-โ‚น313.7736.44%
2020-โ‚น229.97-21.84%
2019-โ‚น294.21-24.58%
2018-โ‚น390.11675.93%
2017-โ‚น50.28-68.05%
2016-โ‚น157.35168.25%
2015-โ‚น58.66-55%
2014-โ‚น130.353400%
2013-โ‚น3.72-108.68%
2012โ‚น42.9224.49%
2011โ‚น34.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น126.62-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,144-46,148.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,334-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น637.78-13,800.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น680.63-14,720.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น322.15-7,020.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น164.80 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA